Study of Osteoporosis Medications’ Impact on Dental Implants Proves Inconclusive
The use of certain antiresorptive drugs to treat osteoporosis can increase the risk of medication-related osteonecrosis of the jaw (MRONJ) among patients with.
Dentistry Today is The Nation’s Leading Clinical News Magazine for Dentists. Here you can get the latest dental news from the whole world quickly.
The use of certain antiresorptive drugs to treat osteoporosis can increase the risk of medication-related osteonecrosis of the jaw (MRONJ) among patients with.
As part of its mission to foster the highest ideals of research, the Osseointegration Foundation said, it is providing important financial support to.
Researchers at the UCLA School of Dentistry have identified the role a critical enzyme plays in skeletal aging and bone loss, putting them.
Regulatory T cells can lose their ability to regulate bone loss and begin promoting inflammation, according to researchers at the Forsyth Institute and.
Researchers at the University of Illinois at Chicago (UIC) have determined, for the first time, how materials come together at the molecular level.
Laser irradiation inhibits the expression of the osteogenesis inhibitor protein sclerostin without causing inflammation, providing a potential therapeutic option for osteoporosis, according to.
Researchers at the University of California Los Angeles (UCLA) School of Dentistry have developed a nanoparticle that could improve treatment for bone defects.
Nicola Partridge, PhD, a professor of basic science and craniofacial biology at the New York University (NYU) College of Dentistry, has been named.
Researchers from the UCLA School of Dentistry have provided insight into how the mechanical process of bone loss works. They also have identified.
Researchers in California report a breakthrough to prevent damage to the jaw, a side effect suffered by some people undergoing treatment for cancer.